Dirk Eulberg
Impact in
- Hepatology top 1%
- Liver physiology and pathology
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes
Papers in
- Oncology 15
- Chemokine receptors and signaling 11
- Immunology 13
- Immune cells in cancer 6
- Co-authors
- Sven Klußmann (18 shared papers)Frank Tacke (6 shared papers)Tom Luedde (5 shared papers)Christian Trautwein (5 shared papers)Michael Schlömann (5 shared papers)Hans‐Joachim Anders (11 shared papers)Felix Heymann (3 shared papers)Christer Baeck (3 shared papers)
- Journals
- Journal of Bacteriology (4 papers)American Journal Of Pathology (3 papers)Nephrology Dialysis Transplantation (2 papers)Annals of Oncology (2 papers)Blood (2 papers)
- Partner nations
- GermanyNetherlandsUnited States
In The Last Decade
Dirk Eulberg
46 papers receiving 3.9k citations
Dirk Eulberg's Hit Papers
Peers
Comparison fields: 5 of 128
- Hepatology 606
- Nephrology 363
- Immunology 834
- Molecular Biology 1.6k
- Pollution 269
Countries citing papers authored by Dirk Eulberg
This map shows the geographic impact of Dirk Eulberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Eulberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Eulberg more than expected).
Fields of papers citing papers by Dirk Eulberg
This network shows the impact of papers produced by Dirk Eulberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Eulberg. The network helps show where Dirk Eulberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk Eulberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury Hit paper breakdown → | 2011 | 527 |
| 2 | 2016 | 283 | |
| 3 | 2014 | 242 | |
| 4 | 2014 | 224 | |
| 5 | 2016 | 172 | |
| 6 | 2007 | 157 | |
| 7 | 2003 | 152 | |
| 8 | 2017 | 150 | |
| 9 | 2009 | 140 | |
| 10 | 2013 | 132 | |
| 11 | 2008 | 125 | |
| 12 | 2004 | 124 | |
| 13 | 1998 | 116 | |
| 14 | 2014 | 116 | |
| 15 | 2005 | 113 | |
| 16 | 2009 | 112 | |
| 17 | 2011 | 104 | |
| 18 | 2010 | 98 | |
| 19 | 2018 | 94 | |
| 20 | 1997 | 89 |
About Dirk Eulberg
Dirk Eulberg is a scholar working on Oncology, Immunology, Hematology, Molecular Biology and Nephrology, having authored 46 papers that have together received 4.0k indexed citations. Recurring topics across this work include Chemokine receptors and signaling (11 papers), Immune cells in cancer (6 papers), RNA Interference and Gene Delivery (5 papers), Microbial Metabolic Engineering and Bioproduction (5 papers), Advanced biosensing and bioanalysis techniques (5 papers), Systemic Lupus Erythematosus Research (4 papers), Enzyme Structure and Function (4 papers) and Liver physiology and pathology (4 papers). The work is most often cited by research in Hepatology (606 citations), Nephrology (363 citations), Immunology (834 citations), Molecular Biology (1.6k citations) and Pollution (269 citations). Dirk Eulberg has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Sven Klußmann, Frank Tacke, Tom Luedde, Christian Trautwein, Michael Schlömann, Hans‐Joachim Anders, Felix Heymann, Christer Baeck, Onkar P. Kulkarni and L. A. Golovleva. Their work appears in journals such as Journal of Bacteriology, American Journal Of Pathology, Nephrology Dialysis Transplantation, Annals of Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.